← Back to screener

CONMED Corp CNMD

Rank #652 · NYSE · $1.4B market cap
Audited by PricewaterhouseCoopers LLP, no going-concern flag in the latest filing.
Score
61.1
P/E
21.2
P/B
1.83
ROE
8.6%
Op. Margin
9.7%
Debt Ratio
180%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★☆☆
Good

P/E 21.2x, P/B 1.83x. Ranks in the top 31% of the universe.

Profitability ★★★☆☆
Average

ROE 8.6%. Ranks in the top 46% of the universe.

Safety ★★☆☆☆
Average

Debt ratio 180%. Ranks in the top 59% of the universe.

Growth ★★★★☆
Excellent

Revenue growth of 19.1% year over year. Ranks in the top 20% of the universe.

Growth is the relative strength · Safety is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$0.0B$0.0B$0.5B–74
2012–$0.1B$0.0B$0.6B–63
2013–$0.0B$0.0B$0.6B–80
2014–$0.1B$0.0B$0.6B–84
2015–$0.1B$0.0B$0.6B–85
2016–$0.1B$0.0B$0.6B–85
2017–$0.1B$0.0B$0.6B–129
2018$0.8B$0.0B$0.0B$0.6B4.9124
2019$0.8B$0.0B$0.1B$0.6B5.9122
2020$0.9B$0.1B$0.0B$0.6B8.3169
2021$1.0B$0.1B$0.0B$0.7B8.3157
2022$0.9B$0.0B$0.0B$0.7B5.3138
2023$1.0B$0.1B$0.1B$0.7B10.9219
2024$1.0B$0.1B$-0.1B$0.8B6.7187
2025$1.2B$0.1B$0.1B$0.7B9.7180

← See the full screener